Company Overview
High Tide Inc. operates within the Healthcare sector as a Pharmaceutical Retailer, engaging in cannabis retail business across Canada, the United States, and international markets. The company generates revenue through three distinct operational segments: Bricks and Mortar, E-commerce, and Medical Cannabis Distribution, while also manufacturing and distributing consumption accessories alongside cannabis and hemp-derived products. The firm maintains a significant operational scale with a market capitalization of $203.04M, an annual revenue of $629.85M, and an employee count of 1832. These valuation and revenue figures indicate that High Tide Inc. holds a substantial position within its specific niche, managing a large workforce to support a diverse product portfolio that spans physical retail locations and digital commerce channels.
Financial Health
The company reported revenue of $629.85M for the trailing twelve months, yet it recorded a net income of -$46.734M and an EBITDA of $29.05M. The substantial gap between the positive revenue and the significant negative net income reveals a cost structure where operating expenses, likely including high overheads associated with retail locations and distribution logistics, heavily outweigh gross profits before accounting for interest and taxes. Despite the net loss, the business generated positive free cash flow of $7.70M, which provides a degree of financial flexibility by allowing the company to fund operations or strategic initiatives without relying solely on external financing. The company's profitability margins reflect this challenging cost environment, with a gross margin of 25.8%, an operating margin of 2.3%, and a negative profit margin of -7.4%. The low operating margin suggests that while the core business model generates cash, non-operating costs or specific segment losses are eroding overall profitability. On the balance sheet, the company holds $37.35M in cash against $112.50M in debt, resulting in a debt-to-equity ratio of 110.31, which characterizes a highly leveraged financial structure. Liquidity is maintained at a current ratio of 1.43, indicating that current assets are sufficient to cover short-term obligations, though the margin of safety is moderate. Return on Equity stands at -39.7% while Return on Assets is 3.9%, metrics that collectively reveal that management effectiveness is currently challenged by equity dilution or losses, yet the company retains some efficiency in utilizing its total asset base to generate earnings relative to its size.
Valuation Assessment
Valuation metrics for High Tide Inc. present a complex picture, with a trailing P/E ratio listed as N/A due to the lack of positive earnings, while the forward P/E is projected at 16.33. The discrepancy between the unavailable trailing P/E and the forward P/E implies that the market expects a significant turnaround in earnings trajectory to achieve profitability in the future. The price-to-book ratio is 3.16, indicating that the market prices the company at a premium of over three times its book value, likely reflecting intangible assets such as brand value or regulatory licenses in the cannabis sector. Alternative valuation multiples provide further context, with a price-to-sales ratio of 0.32 and an EV/EBITDA of 10.04, suggesting the company is valued conservatively relative to its sales but at a reasonable multiple of its adjusted earnings before interest, taxes, depreciation, and amortization. Regarding price volatility, the stock has traded between a 52-week low of $1.64 and a 52-week high of $4.05. Without a specific current share price provided in the facts, the trading range defines the historical volatility boundaries within which the asset has moved. The beta value is 1.01, which indicates that the stock's price volatility mirrors the broader market movements, showing neither significant amplification nor dampening of systemic risk.
Growth & Income
High Tide Inc. demonstrated robust revenue growth of 25.2% year over year, whereas earnings growth is listed as N/A due to the current unprofitability. The divergence between strong revenue expansion and the absence of earnings growth implies that the company is prioritizing market share acquisition and top-line expansion over immediate profitability. As a non-dividend payer, the company does not distribute a dividend yield or utilizes a payout ratio, meaning all available cash flow is reinvested into the business to fuel growth initiatives rather than being returned to shareholders. This reinvestment strategy is typical for growth-oriented cannabis retailers that must constantly invest in inventory, store expansion, and regulatory compliance to maintain their competitive position. The overall growth and income profile is defined by rapid revenue acceleration coupled with a focus on operational leverage rather than current income generation or shareholder payouts.